naltrexone has been researched along with dihydroxyphenylalanine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE; Wagner, EJ | 1 |
| LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE | 1 |
| Keverne, EB; Remfry, CJ; Rosser, AE | 1 |
| Bardo, MT; Ennis, RB; Neisewander, JL | 1 |
| Durham, RA; Lookingland, KJ; Manzanares, J; Moore, KE | 1 |
| Bardo, MT; Kolta, MG | 1 |
| Durham, RA; Johnson, JD; Lookingland, KJ; Moore, KE | 1 |
| Baumann, MH; Callahan, P; Rabii, J | 1 |
| Carson, RE; Cohen, RM; Doudet, DJ; Wyatt, RJ | 1 |
| Hiramoto, K; Mafune, E; Sugiyama, D; Takahashi, Y; Yamate, Y | 1 |
10 other study(ies) available for naltrexone and dihydroxyphenylalanine
| Article | Year |
|---|---|
Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Female; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Orchiectomy; Ovariectomy; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Sex Characteristics; Tuber Cinereum | 1992 |
Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydrazines; Injections, Intraperitoneal; Male; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Pituitary Gland; Pituitary Gland, Posterior; Rats; Receptors, Opioid, kappa | 1991 |
Restricted exposure of mice to primer pheromones coincident with prolactin surges blocks pregnancy by changing hypothalamic dopamine release.
Topics: Animals; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Naltrexone; Pheromones; Pregnancy; Pregnancy, Animal; Prolactin; Sex Attractants; Time Factors | 1989 |
Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: neurochemical and behavioral evidence.
Topics: Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Male; Morphine; Motor Activity; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Synaptic Transmission | 1988 |
delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Neurons; Rats; Receptors, Opioid, delta | 1993 |
Opioid modulation of amphetamine-stimulated dopamine release and concentration in rat striatal slices.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dihydroxyphenylalanine; Dopamine; Hydrazines; In Vitro Techniques; Male; Morphine; Naltrexone; Narcotics; Neostriatum; Rats; Rats, Sprague-Dawley | 1993 |
Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Analgesics; Animals; Cerebral Ventricles; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Agonists; Dynorphins; Hypothalamus; Hypothalamus, Middle; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Prolactin; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Opioid, kappa | 1996 |
Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus, Anterior; Lactation; Male; Median Eminence; Naltrexone; Neurons; Preoptic Area; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin; Sucking Behavior | 1996 |
Opiate receptor avidity is reduced bilaterally in rhesus monkeys unilaterally lesioned with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Brain; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Infusions, Parenteral; Limbic System; Macaca mulatta; Naltrexone; Narcotic Antagonists; Organ Specificity; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tomography, Emission-Computed | 1999 |
The gender differences in the inhibitory action of UVB-induced melanocyte activation by the administration of tranexamic acid.
Topics: Adrenocorticotropic Hormone; alpha-MSH; Animals; Antifibrinolytic Agents; beta-Endorphin; Dihydroxyphenylalanine; Ear; Estradiol; Estrogen Receptor beta; Eye; Female; Male; Melanocytes; Mice; Mice, Inbred DBA; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Naltrexone; Narcotic Antagonists; p38 Mitogen-Activated Protein Kinases; Receptors, Opioid, mu; Selective Estrogen Receptor Modulators; Sex Factors; Skin; Tamoxifen; Tranexamic Acid; Ultraviolet Rays | 2016 |